Correction: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
Read the full articleYou might also wanna read
Nature research paper: Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover
Nature research paper: Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover
Chromobox 3 assembles an epigenetic complex contributing to cystathionine γ-lyase–mediated protection against aortic aneurysm/dissection
Chromobox 3 forms an epigenetic complex aiding cystathionine γ-lyase (CSE) in vascular protection. CSE deficiency in vascular smooth muscle
Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.
abcnews.com·1mo agoImpact of a whole food, plant-based diet on LDL-cholesterol and cardiovascular risk factors in adults with heterozygous familial hypercholesterolemia: a randomized, two-period, two-treatment, crossover, fully controlled feeding trial
Study shows WFPB diet significantly lowers LDL-C and CVD risk in HeFH adults compared to SAD. A potential breakthrough for those with this g
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Conditions : Plaque Psoriasis; Metabolic Dysfunction-Associated Steatotic Liver Disease Sponsors : Novartis Pharmaceuticals Not yet recruiti
MARCH7 identified as key regulator suppressing ferroptosis through iron homeostasis control
MARCH7 prevents ferroptosis by regulating intracellular iron release and extracellular iron uptake. A small molecule stabilizer, EmodAn, off
Comments
Sign in to join the conversation.
No comments yet. Be the first.